Surgery – Diagnostic testing – Measuring or detecting nonradioactive constituent of body...
Reexamination Certificate
2005-03-01
2005-03-01
Winakur, Eric F. (Department: 3736)
Surgery
Diagnostic testing
Measuring or detecting nonradioactive constituent of body...
C600S549000
Reexamination Certificate
active
06860851
ABSTRACT:
Vulnerable plaque is identified through a diagnostic method by identifying pathologic markers such as C-reactive proteins or pH change generated by the pathologic site. First and second detectors are advanced through a blood vessel with each of the detectors selected to detect the pathological marker. The detectors are spaced apart while seeking the marker. Differential concentration of the pathological marker as measured by the first and second detectors indicates a presence of the pathological site in proximity to at least one of the detectors.
REFERENCES:
patent: 6541265 (2003-04-01), Leeuwenburgh
patent: 6712771 (2004-03-01), Haddock et al.
patent: 20020115931 (2002-08-01), Strauss et al.
patent: 20040073132 (2004-04-01), Maahs et al.
Conrad Timothy R.
Knudson Mark B.
Tweden Katherine S.
EnteroMedics Inc.
Kremer Matthew
Winakur Eric F.
LandOfFree
Vulnerable plaque diagnosis and treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vulnerable plaque diagnosis and treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vulnerable plaque diagnosis and treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3387161